NewsRoom Articles - Page 72 of 541

MondayFeb 13, 2023 4:20 am

420 with CNW — Study Shows That Long-Term Use of Medical Cannabis Leads to Lower Opioid Dosages

A recent study published by the American Medical Association (AMA) found that patients with chronic pain who used medical cannabis for more than a month experienced a significant drop in the amount of opioids they were prescribed. The study, conducted by researchers at the New York Department of Health in collaboration with City University of New York and the Marijuana Management Office, examined 8,165 patients registered in the state's medical cannabis program. The researchers used data from the state’s medical marijuana programs from 2017 to 2019 to track how patients' opioid prescriptions changed over time. The data included patients who…

FridayFeb 10, 2023 4:20 pm

420 with CNW — New Study Shows That Marijuana Legalization Hasn’t Worsened Drug Problem

Colorado is home to one of the largest legal cannabis markets in not just the United States but the entire globe. The industry has generated billions in tax dollars and employed tens of thousands of workers, after being launched barely more than a decade ago. However, cannabis legalization in the state didn’t receive 100% support because some feared that legalizing the controversial plant would open up Colorado to criminal activity. In fact, most of the legalization campaigns around the country had to contend with claims that legalizing cannabis would lead to increased drug use among the youth and significantly increase…

FridayFeb 10, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expecting Additional Growth in 2023, Including IND Filing and IND Clinical Study

In addition to a recently released shareholder update letter from the company’s CEO, Chris Bunka, Lexaria Bioscience has now released a new investor presentation Despite 2022 inflationary conditions, Lexaria has seen growth company-wide – including hitting annual budgets +/- 2% over the last two years Lexaria’s patented DehydraTECH(TM) technology offers more effective delivery of active pharmaceutical ingredients into the bloodstream and brain tissue with 28 patents granted and roughly 50 patent applications pending worldwide For Q1 2023, Lexaria expects additional results from its hypertension study HYPER-H21-4, dosing completion in its animal dementia study and diabetes study, dosing completion in human…

FridayFeb 10, 2023 4:20 am

420 with CNW — Maryland Legislators Announce Proposed Law to Operationalize Voter-Approved Marijuana Legalization

Months after Maryland voters approved a ballot referendum to legalize marijuana, state legislators have unveiled a proposed bill to tax and regulate cannabis. Senators Brian Feldman and Antonio Hayes are sponsoring the Senate version of the bill while Delegates C.T. Wilson and Vanessa Atterbeary are carrying the House version. With the law that legalized the possession of up to 1.5 ounces of cannabis for adults taking effect on July 1, 2023, the proposals are meant to prepare the state for regulating a commercial cannabis market. The proposals would levy a 6% tax for the first fiscal year beginning this summer…

ThursdayFeb 09, 2023 4:20 pm

420 with CNW — 2024 Adult-Use Marijuana Campaign Notches Major Victory in Florida

The possibility of legalizing recreational adult-use cannabis in Florida is becoming more visible. This is after a draft constitutional reform that might end recreational cannabis prohibition in Florida passed its initial procedural hurdle. However, before it is presented at the polls next year, it must meet two additional requirements. For the legal and economic impact examination, the "Safe and Smart Florida" commission had to gather at least 222,899 verifiable voter signatures. Florida’s highest court — the Supreme Court — will review the suggested phrasing to make sure it isn't misleading before it appears on the poll. The potential impacts on the federal…

ThursdayFeb 09, 2023 9:00 am

REZYFi, Inc. Provides the Cannabis Industry with Critical Financing Options and Services Still Not Available with Traditional Banking Institutions

Cannabis businesses continue to face challenges finding opportunities for financing despite the continued drive for legalization REZYFi is pivotal providing much-needed support to the cannabis industry through two wholly owned subsidiaries – REZYFi Lending and ResMac Inc. For 2023, combined cannabis industry sales are projected to reach $38.8 billion In recent years, the cannabis industry has seen significant changes – with 39 states legalizing cannabis for medicinal use and 21 states allowing recreational use. For 2023, the combined sales are projected to reach $38.8 billion for the industry (https://cnw.fm/LSWNV). In spite of this significant growth, there is a challenge that cannabis…

ThursdayFeb 09, 2023 4:20 am

420 with CNW — Federal Data Shows Trucker Shortage Worsening Due to Marijuana Testing

Although dozens of states now allow the sale and consumption of either medical or recreational cannabis, federal law still outlaws the controversial drug. As a result, plenty of consumers have found themselves facing repercussions for consuming legal cannabis, especially employees in federal agencies and certain industries. According to recent data from the Department of Transportation (DOT), commercial truckers are the latest class of employees to be affected by cannabis testing requirements. The Federal Motor Carrier Safety Administration reports that tens of thousands of truckers failed cannabis tests after federally mandated screenings. Many of them have refused to return to work,…

WednesdayFeb 08, 2023 4:20 pm

420 with CNW — AMA Study Concludes Cannabis Legalization Doesn’t Increase Psychosis Prevalence

A recent study published by the American Medical Association has revealed that there has been no notable increase in the number of diagnoses for psychosis in states where cannabis is legal compared to those where it is not. To investigate the possibility that cannabis legalization could be associated with higher rates of psychosis, which some prohibitionists have used as evidence against legalization, researchers at Pennsylvania University, Stanford University and the Department of Veterans Affairs examined data on more than 63 million beneficiaries of health insurance from 2003 to 2017. The authors examined Medicare Advantage and commercial claims data in particular…

WednesdayFeb 08, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) – Technology Behind Patented Disruptive DehydraTECH(TM) Drug Delivery Platform

Lexaria has developed the DehydraTECH drug delivery technology, which enhances the performance of multiple categories of fat-soluble active molecules and drugs DehydraTECH has been shown to increase intestinal bioabsorption of certain bioactive compounds by as much as 27 times, with its onset of action being as little as 1.5 minutes The technology is also expected to lower the overall drug costs because it delivers more active molecules to the blood plasma and brain, thus necessitating lower dosing, all while resulting in cost-effective manufacturing DehydraTECH is protected by 28 patents granted worldwide, with approximately 50 more pending Speaking during a late…

WednesdayFeb 08, 2023 4:20 am

420 with CNW — FDA Passes the Buck, Gives Congress Plenty to Consider About CBD Marketing

The current tense situation regarding CBD-containing products will be maintained for the time being as a result of the U.S. Food and Drug Administration’s recent announcement that it will not regulate those products, instead delegating that responsibility to Congress. This adds to the workload for a Congress that is already becoming more acrimonious and creates more uncertainty for businesses considering entering the $4 billion-plus CBD market. Congress must make decisions regarding intoxicating cannabinoids derived from hemp, such as delta-10 THC and delta-8, in addition to tackling broader cannabis policy reform, which includes banking access, tax relief and the issue of…

News and publishing service for cannabis related companies

Contact us: 303.498.7722